BPMC

Blueprint Medicines Corporation Common Stock

$83.93 +$6.40 +7.63%


Own 1 of BPMC at $79.75 which is 0.13% of the portfolio.

+$4.18 (+5.24%)

Shares Bought2
Shares Sold1
Total3
Shares Owned1
Last Price$83.93
Total Return$9.67
Range Today$77.53 - $84.17
52 Week Range$31.38 - $92.00
Open$77.53
Market Cap$3.29B
Volume/Average151.71K/453.94K
P/E Ratio-
Dividend/Yield-




Blueprint Medicines Corp. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes BLU-285 and BLU-554 for the treatment of gastrointestinal stromal tumors, systemic mastocytosis, and leukemia. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.


Open Positions

Buy Date Buy Price Quote Return $ Return % Owners
18-01-12 19:28 $79.75 $83.93 +$4.18 +5.24% funkmasterflexion

Closed Positions

Buy Date Sell Date Buy Price Sell Price Return $ Return % Owners
17-11-21 18:16 17-11-22 20:54 $64.75 $70.24 +$5.49 +8.48% funkmasterflexion michrob